Skip to content
Screener

Zymeworks ZYME Total Current Liabilities

Total Current Liabilities at other companies

Pfizer logo
PfizerPFE
$34.35B-5.8%
Amgen logo
AmgenAMGN
$25.5B+24.5%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$4.25M-41.9%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$32.95M0.0%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$53.19M-20.6%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$46.74M-27.8%

Other financials

Income statement

See full
Revenue$4.6M-90.6%
Operating income-$42.2M-6,158%
Net income-$45.0M-2,043%
EPS (diluted)-$0.62-2,167%

Balance sheet

See full
Cash & equivalents$179.4M+82.6%
Total debt$16.0M-14.3%
Total equity$80.4M-76.0%
Total assets$397.0M-2.8%

Cash flow

See full
Operating cash flow-$31.9M-365%
CapEx$216.0K+1,250%
Free cash flow-$31.9M-376%

Valuation

See full
Market cap$1.7B+83.2%
Enterprise value$1.54B+81.1%
P/S45.8×+38.3×

Profitability

See full
Operating margin-419%-518pp
Net margin-404%-489pp
FCF margin-324.7%-366pp

Returns & leverage

See full
Return on equity-72.3%-117pp
Debt / equity0.2×+0.1×
Current ratio6.3×-1.4×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: Zymeworks’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001937653-26-000047
AssetsJune 30,2026 / (unaudited)December 31,2025
Income tax payable4583
Current portion of operating lease liability3,3043,471
Deferred revenue16,4362,418
Total current liabilities47,24342,318
Long-term portion of operating lease liability12,70314,796
Deferred revenue14,606
Liability related to sale of future royalties252,631
Other long-term liabilities278278

Item 1. Financial Statements

FAQ

What is Zymeworks's total current liabilities?
Zymeworks (ZYME) reported total current liabilities of $47.24M in Q2 2026.
How has Zymeworks's total current liabilities changed year-over-year?
Zymeworks's total current liabilities increased by 22.7% year-over-year, from $38.5M to $47.24M.
What is the long-term trend for Zymeworks's total current liabilities?
Over 4 years (2021 to 2025), Zymeworks's total current liabilities has grown at a -12.4% compound annual growth rate (CAGR), from $71.85M to $42.32M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about Zymeworks's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude